Sponsor or institution

Clinical trials and research at Shanghai Pharmaceuticals Holding Co., Ltd

• 13Clinical trials
• 1Country

Newest trials

All recruiting trials (13)

• Evaluating SPH9788 Tablets in Healthy Adults

  This study is testing the safety of SPH9788 tablets in healthy adults aged 18 to 45 to see if there are any side effects.

  Recruiting Phase 1 Shanghai Pharmaceuticals Holding Co., Ltd · Shanghai · NCT06839131

• Testing SPH7485 tablets for advanced solid tumors

  This study is testing if SPH7485 tablets can help people with advanced solid tumors feel better and stay safe while taking the medication.

  Recruiting at 6 sites Phase 1 Shanghai Pharmaceuticals Holding Co., Ltd · Changsha and 5 other locations · NCT06487455

• Evaluating SPH7854 Granules in Healthy Individuals

  This study is testing the safety of SPH7854 granules in healthy people to see if there are any side effects compared to a placebo.

  Recruiting Early Phase 1 Shanghai Pharmaceuticals Holding Co., Ltd · Chengdu · NCT06483373

• Treatment of Her2-positive Biliary Tract or Colorectal Cancer with SPH5030 Tablets

  This study is testing if SPH5030 tablets can help people with advanced Her2-positive biliary tract or colorectal cancer feel better and manage their disease.

  Recruiting at 30 sites Phase 2 Shanghai Pharmaceuticals Holding Co., Ltd · Beijing and 29 other locations · NCT06434597

• Testing T3011 for advanced melanoma treatment

  This study is testing a new treatment called T3011 to see if it can help people with advanced melanoma feel better and manage their condition.

  Recruiting at 7 sites Phase 1/2 Shanghai Pharmaceuticals Holding Co., Ltd · Beijing and 6 other locations · NCT06214156

• Combining T3011 with PD-1/PD-L1 inhibitors for advanced solid tumors

  This study is testing if a new treatment called T3011, when combined with existing cancer drugs, can help people with advanced solid tumors feel better and improve their health.

  Recruiting at 22 sites Phase 1/2 Shanghai Pharmaceuticals Holding Co., Ltd · Anyang and 21 other locations · NCT06214143

• Evaluating SPH4336 alone or with Cadonilimab for advanced solid tumors

  This study is testing whether a new drug called SPH4336, alone or with another drug called Cadonilimab, can help people with advanced solid tumors who can't have surgery or other local treatments.

  Recruiting at 16 sites Phase 1/2 Shanghai Pharmaceuticals Holding Co., Ltd · Fuzhou, Fujian and 15 other locations · NCT05944224

• Combining SPH4336 with endocrine therapy for breast cancer patients with brain metastases

  This study is testing if adding SPH4336 tablets to hormone therapy can help breast cancer patients with brain metastases feel better when other treatments aren't an option.

  Recruiting at 25 sites Phase 2 Shanghai Pharmaceuticals Holding Co., Ltd · Hefei, Anhui and 24 other locations · NCT05872347

• Using SPH4336 with hormone therapy for advanced breast cancer

  This study is testing a new treatment called SPH4336 combined with hormone therapy to see if it helps people with advanced breast cancer that hasn't responded to other treatments.

  Recruiting at 22 sites Phase 2/3 Shanghai Pharmaceuticals Holding Co., Ltd · Guangzhou, Guangdong and 21 other locations · NCT05860465

• New treatment for advanced breast cancer using SPH4336 and letrozole

  This study is testing if a new treatment combining SPH4336 with letrozole can help women with advanced breast cancer feel better compared to just taking letrozole with a placebo.

  Recruiting at 9 sites Phase 2/3 Shanghai Pharmaceuticals Holding Co., Ltd · Fuzhou, Fujian and 8 other locations · NCT05744687

• Evaluating LT3001 for treating acute ischemic stroke

  This study is testing if a new drug called LT3001 can help people who have had an acute ischemic stroke feel better and recover more effectively.

  Recruiting at 28 sites Phase 2 Shanghai Pharmaceuticals Holding Co., Ltd · Beijing, Beijing Municipality and 27 other locations · NCT05686642

• Evaluating SPH5030 tablets for advanced HER2-positive solid tumors

  This study is testing if SPH5030 tablets are safe and tolerable for people with advanced HER2-positive solid tumors that haven't responded to other treatments.

  Recruiting at 17 sites Early Phase 1 Shanghai Pharmaceuticals Holding Co., Ltd · Hefei, Anhui and 16 other locations · NCT05245058

• Evaluating B001 Injection for Neuromyelitis Optic Spectrum Disorder

  This study is testing a new injection called B001 to see if it can help people with neuromyelitis optic spectrum disorder feel better and reduce their symptoms.

  Recruiting at 4 sites Early Phase 1 Shanghai Pharmaceuticals Holding Co., Ltd · Beijing, Beijing Municipality and 3 other locations · NCT05145361

Quick answers

How many clinical trials run by Shanghai Pharmaceuticals Holding Co., Ltd are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Early Phase 1: 3, Phase 1/2: 3, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →